We are live on ! Find out more
Asset Management One

Asset Management One Portfolio holdings

AUM $39B
1-Year Est. Return 37.51%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.82%
5 Year Est. Return
+143.22%
10 Year Est. Return
+503.7%
AUM
$26.1B
AUM Growth
-$788M
Cap. Flow
-$692M
Cap. Flow %
-2.65%
Top 10 Hldgs %
25.78%
Holding
1,079
New
35
Increased
305
Reduced
668
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 20.72%
2 Healthcare 10.52%
3 Financials 10.43%
4 Consumer Discretionary 9.76%
5 Real Estate 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRC icon
451
Kilroy Realty
KRC
$4.6B
$10.8M 0.04%
162,665
-16,492
-9% -$1.11M
HZNP
452
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.8M 0.04%
98,228
-1,092
-1% -$113K
DOV icon
453
Dover
DOV
$27.5B
$10.7M 0.04%
69,011
-3,516
-5% -$582K
BRX icon
454
Brixmor Property Group
BRX
$9.67B
$10.7M 0.04%
482,394
-66,798
-12% -$1.53M
OMC icon
455
Omnicom Group
OMC
$21.8B
$10.7M 0.04%
146,982
+7,239
+5% +$538K
RF icon
456
Regions Financial
RF
$26.3B
$10.6M 0.04%
495,483
-31,935
-6% -$635K
VFC icon
457
VF Corp
VFC
$5.87B
$10.5M 0.04%
157,449
-2,606
-2% -$200K
BIDU icon
458
Baidu
BIDU
$36.5B
$10.5M 0.04%
68,410
+18,678
+38% +$3.07M
WAT icon
459
Waters Corp
WAT
$37.3B
$10.5M 0.04%
29,379
+29
+0.1% +$11.4K
ACC
460
DELISTED
American Campus Communities, Inc.
ACC
$10.5M 0.04%
216,376
-16,062
-7% -$797K
CZR icon
461
Caesars Entertainment
CZR
$6.03B
$10.4M 0.04%
93,077
-1,138
-1% -$111K
REET icon
462
iShares Global REIT ETF
REET
$5.12B
$10.4M 0.04%
379,000
-55,000
-13% -$1.58M
EXPE icon
463
Expedia Group
EXPE
$35.2B
$10.4M 0.04%
63,374
-1,885
-3% -$291K
CRL icon
464
Charles River Laboratories
CRL
$11.3B
$10.3M 0.04%
24,901
+953
+4% +$396K
NDAQ icon
465
Nasdaq
NDAQ
$53.2B
$10.3M 0.04%
159,687
+291
+0.2% +$18.3K
LNT icon
466
Alliant Energy
LNT
$18.3B
$10.2M 0.04%
182,415
-19,308
-10% -$1.14M
CHGG icon
467
Chegg
CHGG
$118M
$10.2M 0.04%
149,634
+37,121
+33% +$3.02M
CTLT
468
DELISTED
CATALENT, INC.
CTLT
$10.2M 0.04%
76,389
-6,005
-7% -$750K
TXG icon
469
10x Genomics
TXG
$6.28B
$10.2M 0.04%
69,689
-411
-0.6% -$70.6K
PKG icon
470
Packaging Corp of America
PKG
$22.2B
$10.1M 0.04%
73,804
+31,170
+73% +$4.45M
DVN icon
471
Devon Energy
DVN
$50.9B
$10.1M 0.04%
285,233
-7,646
-3% -$217K
HR
472
DELISTED
Healthcare Realty Trust Incorporated
HR
$10M 0.04%
336,899
-33,781
-9% -$1.04M
ALNY icon
473
Alnylam Pharmaceuticals
ALNY
$27.4B
$9.94M 0.04%
52,648
-298
-0.6% -$55.9K
TRU icon
474
TransUnion
TRU
$15.4B
$9.93M 0.04%
88,456
+1,361
+2% +$160K
ONC
475
BeOne Medicines Ltd
ONC
$33.4B
$9.93M 0.04%
27,369
+386
+1% +$126K

Similar funds

Asset Management One's Q3 2021 Portfolio in Review

As of Q3 2021, Asset Management One held 1,079 positions worth $26.1B, down 2.9% from $26.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Asset Management One's Q3 2021 filing shows 35 new, 305 increased, 668 reduced and 33 closed positions. Its largest new stake was AMC Entertainment Holdings: 21,788 shares worth $8.29M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $43.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Asset Management One's largest Q3 2021 buy was AMC Entertainment Holdings: 21,788 shares worth $8.29M.
  • Asset Management One added most to Vanguard Real Estate ETF in Q3 2021, an estimated $20.6M increase.
  • Asset Management One's biggest Q3 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $43.3M.
  • Asset Management One fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $19.5M.
  • Asset Management One's ten largest holdings make up 26% of its $26.1B portfolio in Q3 2021.
  • Asset Management One opened 35 new positions and closed 33 in Q3 2021.
  • Asset Management One's portfolio value fell 2.9% quarter-over-quarter to $26.1B.

Based on Asset Management One's 13F filing for Q3 2021, filed 2 Nov 2021.